National Peroxide Ltd Falls 4.79%: Valuation Shift and Technical Upgrade Shape Volatile Week

1 hour ago
share
Share Via
National Peroxide Ltd experienced a challenging week on the BSE, closing at Rs.612.00 on 22 May 2026, down 4.79% from the previous Friday’s close of Rs.642.80. This decline contrasted with the Sensex’s modest 0.50% gain over the same period, highlighting a divergence between the stock’s performance and the broader market. The week was marked by significant valuation shifts and a notable upgrade in investment rating, yet short-term price volatility and mixed technical signals influenced investor sentiment.

Key Events This Week

18 May: Valuation shifts to attractive amid strong market returns

19 May: Upgraded to Buy on improved technicals and valuation

22 May: Week closes at Rs.612.00 (-4.79%)

Week Open
Rs.642.80
Week Close
Rs.612.00
-4.79%
Week High
Rs.615.30
vs Sensex
-5.29%

18 May 2026: Valuation Shifts to Attractive Amid Strong Market Returns

National Peroxide Ltd opened the week sharply lower at Rs.602.10, a decline of 6.33% from the previous close of Rs.642.80. This drop occurred despite the Sensex falling only 0.35%, indicating stock-specific pressures. The valuation narrative evolved as the company’s price-to-earnings (P/E) ratio settled at 31.55, reflecting a shift from very attractive to attractive valuation status. The price-to-book value ratio remained close to parity at 1.01, signalling that the stock was trading near its net asset value.

Comparatively, National Peroxide’s valuation metrics were more appealing than many peers in the commodity chemicals sector, with enterprise value to EBITDA at 9.85, substantially lower than competitors such as Titan Biotech and Sanstar Chemicals. The company’s PEG ratio of 0.05 suggested strong earnings growth relative to price, a positive sign amid modest returns on capital employed (3.44%) and equity (3.21%).

Despite the valuation appeal, the stock’s micro-cap status and relatively low profitability metrics likely contributed to the initial price weakness on 18 May, as investors digested the nuanced shift in sentiment.

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

19 May 2026: Upgrade to Buy on Improved Technicals and Valuation

The following day, National Peroxide’s investment rating was upgraded from 'Hold' to 'Buy' by MarketsMOJO, reflecting a comprehensive improvement in technical indicators, valuation, and financial performance. The stock rebounded modestly to Rs.610.35, gaining 1.37%, while the Sensex rose 0.25%.

Technical trends shifted to mildly bullish, with weekly MACD and Know Sure Thing (KST) oscillators turning positive. Bollinger Bands on weekly and monthly charts supported a sustained upward price movement potential, although daily moving averages remained mildly bearish, indicating some short-term caution.

Valuation metrics remained attractive, with a P/E ratio of 30.31 and price-to-book near 0.97. The company’s net-debt-free status and strong quarterly financial results, including a 333.33% growth in net profit for Q4 FY25-26 and an operating profit margin of 17.37%, underpinned the upgrade. Despite these positives, long-term sales growth remained a concern, with a negative annualised decline over five years.

This upgrade highlighted a potential inflection point for National Peroxide, though the stock’s micro-cap classification and modest profitability ratios suggested ongoing risks.

20-22 May 2026: Mixed Price Movements Amid Volatility

On 20 May, the stock declined 2.03% to Rs.597.95 despite the Sensex gaining 0.28%, reflecting continued volatility and investor caution. However, on 21 May, National Peroxide surged 2.90% to Rs.615.30, its weekly high, outperforming the Sensex’s 0.12% gain. This rally aligned with the positive technical outlook and the recent upgrade announcement.

The week closed on 22 May with a slight decline of 0.54% to Rs.612.00, while the Sensex advanced 0.21%. The stock’s weekly performance thus lagged the benchmark, ending the period down 4.79% against the Sensex’s 0.50% rise.

National Peroxide Ltd caught your attention? Explore our comprehensive research report with in-depth analysis of this micro-cap stock – fundamentals, valuations, financials, and technical outlook!

  • - Comprehensive research report
  • - In-depth micro-cap analysis
  • - Valuation assessment included

Explore In-Depth Research →

Daily Price Performance vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-05-18 Rs.602.10 -6.33% 35,114.86 -0.35%
2026-05-19 Rs.610.35 +1.37% 35,201.48 +0.25%
2026-05-20 Rs.597.95 -2.03% 35,299.20 +0.28%
2026-05-21 Rs.615.30 +2.90% 35,340.31 +0.12%
2026-05-22 Rs.612.00 -0.54% 35,413.94 +0.21%

Key Takeaways

Valuation Appeal Amid Mixed Fundamentals: National Peroxide’s valuation metrics remain attractive relative to sector peers, with a low PEG ratio signalling potential undervaluation despite modest profitability. The upgrade to a Buy rating reflects improved technicals and financial trends, particularly the strong quarterly profit growth of 333.33% in Q4 FY25-26.

Short-Term Volatility and Underperformance: The stock’s weekly decline of 4.79% contrasted with the Sensex’s 0.50% gain, highlighting short-term volatility and investor caution. The micro-cap status and modest returns on capital employed and equity contribute to this cautious sentiment.

Technical Indicators Suggest Mild Bullishness: Weekly and monthly technical indicators have turned mildly bullish, supporting potential price recovery. However, daily moving averages remain mildly bearish, indicating some near-term uncertainty.

Long-Term Growth Challenges: Despite recent earnings momentum, the company faces structural headwinds with negative compound annual growth rates in net sales and operating profit over five years, which may temper longer-term optimism.

Conclusion

National Peroxide Ltd’s week was characterised by a complex interplay of valuation improvements, technical upgrades, and price volatility. While the stock’s attractive valuation and strong quarterly earnings growth underpin a positive outlook, the short-term price decline and modest profitability metrics suggest caution. The upgrade to a Buy rating by MarketsMOJO reflects a more favourable risk-reward profile, but investors should remain mindful of the company’s micro-cap status and longer-term growth challenges. Overall, National Peroxide presents a nuanced investment case within the commodity chemicals sector, balancing valuation appeal with operational and market risks.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News